We’ve generated over $500M in 340B revenue for the hospitals we serve. Our unmatched success in overcoming drug manufacturer restrictions comes from years of expertise and proprietary software that gives you a single access point for all of your 340B data.
A Multi-Billion-Dollar Issue
According to its website, “340B ESP allows 340B covered entities and pharmaceutical manufacturers to work collaboratively to resolve duplicate discounts.”
If you’re already aware of 340B ESP and the burdens it places on eligible entities, VytlOne can minimizes those burdens while maximizing savings and ensuring compliance, for the healthcare systems we serve.
The reporting burdens 340B ESP place on covered entities
Covered entities must report twice monthly their covered prescriptions from every TPA with whom they work through 340B ESP. Because every TPA uses a different technology interface, this further complicates matters for already overworked covered entity employees.
Extracting covered prescription data from some TPAs is impossible, due to the lack of available 340B pricing in the 340B wholesaler account.
How we support entities with 340B ESP?
If you choose to report claims data to 340B ESP, well report on your behalf. Then we’ll track 340B price reinstatement by manufacturer, and by contract pharmacy. We’ll also verify 340B price availability for each manufacturer, in each wholesaler account, for each of your contract pharmacies. Once verified pricing has been restored along the entire chain, we’ll work with your TPAs to turn on replenishment and ensure they replenish appropriately.
NOTE:
Each contract pharmacy with whom covered entities have relationships has a separate 340B wholesaler account. Wholesalers have either loaded Wholesale Acquisition Cost (WAC) prices for the restricted National Drug Codes (NDCs), or they’ve removed the NDCs from their 340B account catalog in response to manufacturer restrictions. There are many points along the way where price restoration has to be verified, and subsequent actions must be taken which, of course, we’ll also take on your behalf.
Reporting to 340B ESP
- We track per manufacturer / per pharmacy 340B price eligibility according to what 340B ESP says it is
- We verify in each 340B account by Consumer Pricing and by manufacturer if what 340B ESP says is accurate
- Once we’ve verified each data point, we’ll notify your TPAs of newly restored pricing then ensure that the TPAs request new price files from wholesalers
- Once your TPAs have 340B prices, we’ll order the 340B eligible drugs.
The good news about 340B ESP, for covered entities
One of the health systems VytlOne serves employs three experienced, well trained full time professionals to monitor their system’s 340B claims on a full time basis. Yet during the first six weeks VytlOne of working together, we provided matching justification that generated $187,000 worth of 340B savings that they’d overlooked. Altogether, our efforts have generated tens of millions in 340B savings and revenue for the hospitals we serve.
VytlOne is here to help you with 340B ESP and other manufacturer restrictions.
There are many ways to optimize your 340B drug program savings and benefits while minimizing the likelihood of noncompliance.